Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.
The Art Of The Future: Lisa Ray’s TheUpsideSpace Bring NFTs To Center Stage
This article was orignally published on the Benzinga India portal.